CN114097965A - Preparation method of bitter beverage for relieving pulmonary fibrosis - Google Patents
Preparation method of bitter beverage for relieving pulmonary fibrosis Download PDFInfo
- Publication number
- CN114097965A CN114097965A CN202111439198.XA CN202111439198A CN114097965A CN 114097965 A CN114097965 A CN 114097965A CN 202111439198 A CN202111439198 A CN 202111439198A CN 114097965 A CN114097965 A CN 114097965A
- Authority
- CN
- China
- Prior art keywords
- limonin
- water
- pectin
- glass bottle
- citrus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 26
- 208000005069 pulmonary fibrosis Diseases 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 241000207199 Citrus Species 0.000 claims abstract description 40
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 40
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 claims abstract description 31
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 claims abstract description 31
- 229920001277 pectin Polymers 0.000 claims abstract description 31
- 235000010987 pectin Nutrition 0.000 claims abstract description 31
- 239000001814 pectin Substances 0.000 claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 28
- 238000001914 filtration Methods 0.000 claims abstract description 20
- 229930003935 flavonoid Natural products 0.000 claims abstract description 20
- 235000017173 flavonoids Nutrition 0.000 claims abstract description 20
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 17
- 244000248349 Citrus limon Species 0.000 claims abstract description 16
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 16
- 230000000694 effects Effects 0.000 claims abstract description 14
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 11
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 8
- 238000004140 cleaning Methods 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract description 8
- 229930003944 flavone Natural products 0.000 claims abstract description 8
- 150000002212 flavone derivatives Chemical class 0.000 claims abstract description 8
- 235000011949 flavones Nutrition 0.000 claims abstract description 8
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000004744 fabric Substances 0.000 claims abstract description 5
- 235000012907 honey Nutrition 0.000 claims abstract description 5
- 239000011521 glass Substances 0.000 claims description 31
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 18
- 238000010438 heat treatment Methods 0.000 claims description 15
- 238000001179 sorption measurement Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 12
- 210000001035 gastrointestinal tract Anatomy 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 10
- 238000007789 sealing Methods 0.000 claims description 10
- 210000002784 stomach Anatomy 0.000 claims description 10
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 9
- 240000002319 Citrus sinensis Species 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000013078 crystal Substances 0.000 claims description 9
- 230000006378 damage Effects 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 208000027418 Wounds and injury Diseases 0.000 claims description 8
- 208000014674 injury Diseases 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 7
- 238000000746 purification Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- 230000000840 anti-viral effect Effects 0.000 claims description 6
- 230000009286 beneficial effect Effects 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 241000972672 Phellodendron Species 0.000 claims description 5
- 150000002596 lactones Chemical class 0.000 claims description 5
- 230000001681 protective effect Effects 0.000 claims description 5
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims description 4
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims description 4
- 241000699670 Mus sp. Species 0.000 claims description 4
- 230000000844 anti-bacterial effect Effects 0.000 claims description 4
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims description 4
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims description 4
- 210000003608 fece Anatomy 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims description 4
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims description 4
- 229940025878 hesperidin Drugs 0.000 claims description 4
- 230000002757 inflammatory effect Effects 0.000 claims description 4
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims description 4
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 claims description 3
- 239000004382 Amylase Substances 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 3
- 108010065511 Amylases Proteins 0.000 claims description 3
- 108010006654 Bleomycin Proteins 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 239000004793 Polystyrene Substances 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 claims description 3
- 230000002378 acidificating effect Effects 0.000 claims description 3
- 230000009471 action Effects 0.000 claims description 3
- 235000019418 amylase Nutrition 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 235000019658 bitter taste Nutrition 0.000 claims description 3
- 229960001561 bleomycin Drugs 0.000 claims description 3
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 3
- 238000005238 degreasing Methods 0.000 claims description 3
- 238000001514 detection method Methods 0.000 claims description 3
- 235000013325 dietary fiber Nutrition 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 229930182478 glucoside Natural products 0.000 claims description 3
- 150000008131 glucosides Chemical class 0.000 claims description 3
- 230000005764 inhibitory process Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 230000007246 mechanism Effects 0.000 claims description 3
- 239000012452 mother liquor Substances 0.000 claims description 3
- 239000003208 petroleum Substances 0.000 claims description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 3
- 150000002989 phenols Chemical class 0.000 claims description 3
- 239000000049 pigment Substances 0.000 claims description 3
- 229920002223 polystyrene Polymers 0.000 claims description 3
- 230000001376 precipitating effect Effects 0.000 claims description 3
- 238000003825 pressing Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 238000010898 silica gel chromatography Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 claims description 3
- 238000003786 synthesis reaction Methods 0.000 claims description 3
- 238000004809 thin layer chromatography Methods 0.000 claims description 3
- 230000003176 fibrotic effect Effects 0.000 claims description 2
- 210000004072 lung Anatomy 0.000 claims description 2
- 230000008506 pathogenesis Effects 0.000 claims description 2
- 230000001112 coagulating effect Effects 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000019491 signal transduction Effects 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 abstract description 4
- 206010059866 Drug resistance Diseases 0.000 abstract description 3
- 239000003443 antiviral agent Substances 0.000 abstract description 3
- -1 flavonoid compounds Chemical class 0.000 abstract description 3
- 235000020510 functional beverage Nutrition 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 206010035664 Pneumonia Diseases 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 208000019693 Lung disease Diseases 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 231100000673 dose–response relationship Toxicity 0.000 description 3
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- 201000003838 Idiopathic interstitial pneumonia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000029523 Interstitial Lung disease Diseases 0.000 description 2
- 201000010001 Silicosis Diseases 0.000 description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000004202 respiratory function Effects 0.000 description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical group C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 201000009794 Idiopathic Pulmonary Fibrosis Diseases 0.000 description 1
- 208000004852 Lung Injury Diseases 0.000 description 1
- 206010069363 Traumatic lung injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 208000035474 group of disease Diseases 0.000 description 1
- 208000036971 interstitial lung disease 2 Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 231100000515 lung injury Toxicity 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
- A23L2/04—Extraction of juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/231—Pectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a preparation method of a bitter beverage for relieving pulmonary fibrosis, which comprises the following steps: cleaning fresh fructus Citri Limoniae, drying, peeling, removing seeds, squeezing, filtering with 150 mesh filter cloth, removing residue, and collecting lemon juice; adding citrus flavone, limonin and pectin into lemon juice, adding water and honey, blending, and homogenizing the blended beverage; the invention can solve the problem that the traditional antiviral drugs have large toxic and side effects or are easy to generate drug resistance by applying the limonin and the citrus flavonoid compounds to the functional beverage, and pectin can prolong the retention time of the limonin and the citrus flavonoid in the throat so as to fully exert the efficacy, increase the actual effects of the limonin and the citrus flavonoid and ensure that the bitter beverage has stronger efficacy of relieving the pulmonary fibrosis.
Description
Technical Field
The invention relates to the field of preparation methods of bitter beverages for relieving pulmonary fibrosis, and particularly relates to a preparation method of bitter beverages for relieving pulmonary fibrosis.
Background
Pulmonary fibrosis is the terminal change of a large group of lung diseases characterized by fibroblast proliferation and massive extracellular matrix aggregation with inflammatory injury and tissue structure destruction, namely structural abnormality caused by abnormal repair after normal alveolar tissues are damaged. The causes of most patients with pulmonary fibrosis are unknown, and the group of diseases is called idiopathic interstitial pneumonia, which is a large group of interstitial lung diseases. The most common disease type with pulmonary fibrosis lesion as the main manifestation form in idiopathic interstitial pneumonia is idiopathic pulmonary fibrosis, which is a serious interstitial lung disease that can cause progressive loss of lung function. Pulmonary fibrosis seriously affects the respiratory function of human body, manifested as dry cough and progressive dyspnea, and the respiratory function of patients is continuously worsened with the aggravation of illness and lung injury.
In the prior art, the retention time of limonin and citrus flavone in the throat of the existing bitter drink is short, so that the efficacy of the bitter drink is weak, and the working efficiency of the limonin and the citrus flavone is reduced, so that a preparation method of the bitter drink for relieving pulmonary fibrosis is needed.
Disclosure of Invention
The present invention aims to provide a method for preparing a bitter beverage for alleviating pulmonary fibrosis, so as to solve the problems in the background art.
In order to achieve the purpose, the invention provides the following technical scheme: a preparation method of a bitter beverage for relieving pulmonary fibrosis comprises the following steps:
step one, taking fresh lemons, cleaning, drying, peeling, removing seeds, juicing, filtering by using 150-mesh filter cloth, removing residues, and collecting lemon juice;
adding the citrus flavone, the limonin and the pectin into the lemon juice, adding water and honey for blending, and homogenizing the blended beverage;
and step three, filling the homogenized pulp into a sterilized glass bottle, sealing the glass bottle, sterilizing the glass bottle for 15-20 min at 85-86 ℃, and finally cooling the glass bottle to room temperature to obtain the bitter beverage, wherein the bitter beverage is rich in water-soluble fibers.
Preferably, the purification method of the citrus flavone comprises the following steps:
step one, cleaning and crushing citrus peel, putting the crushed citrus peel and 50-95 v/v% ethanol water solution in an extractor according to the weight ratio of 1: 1-5, extracting for 0.5-1 hour under the reflux state, filtering, and repeating the step for 3 times;
step two, combining the filtered filtrates, concentrating to obtain a citrus peel extract, suspending the obtained citrus peel extract in water, and performing centrifugal filtration to obtain a clear filtrate;
step three, flowing the clear filtrate through an adsorption column filled with pretreated polystyrene type adsorption resin with the granularity of 0.3-1.25 mm at the flow rate of 1.5-8 BV/h at the temperature of 20-30 ℃, wherein the diameter of the adsorption column is as follows: the height ratio is 1: 3-30;
step four, water flows through the adsorption column at the flow rate of 5-10 BV/h; and finally, flowing methanol through the adsorption column at the flow rate of 2-10 BV/h, collecting the obtained liquid, and concentrating to obtain the citrus flavonoid.
Preferably, the purification method of limonin comprises the following steps:
step one, drying and crushing sweet orange seeds, thoroughly degreasing the sweet orange seeds for 24 hours by using petroleum ether (60-90 ℃) in a Soxhlet extractor, extracting the sweet orange seeds for 6 hours by using acetone, concentrating an acetone extracting solution under reduced pressure to dryness, dissolving the acetone extracting solution by using dichloromethane and filtering;
adding isopropanol with 2 times of volume into a dichloromethane solution, uniformly mixing, placing in a refrigerator at 4 ℃, and precipitating a flaky crystal;
step three, recrystallizing the obtained crystal I for 3 times according to the solvent system for determination, evaporating the crystallized mother liquor to dryness, and performing silica gel column chromatography to 100-200 meshes, wherein the eluent is ethyl acetate: methanol 95: 5, detecting with silica gel G thin layer chromatography plate, spraying Ehrlich reagent, mixing the components with the same red spot shift value, and limonin crystal.
Preferably, the pectin purification method comprises the following steps:
step one, soaking lemon peel and squeezed pomace in clear water for half an hour, heating to 90 ℃ for 5 minutes, pressing to remove juice, and rinsing with clear water for several times, so that most of glucoside, pigment and other impurities can be removed, and most of bitter taste is removed;
step two, pouring the ground raw materials into an extraction pot, adding 4 times of water, adding sulfurous acid to adjust the pH value to 1.8-2.7, introducing steam, heating to 95 ℃ while stirring, and keeping for 45-60 minutes to extract most of pectin;
filtering the sleeve extraction material through a filter press, separating impurities by using a 7000 r/min high-speed centrifuge, and then rapidly cooling to about 50 ℃; adding 1-2% amylase to hydrolyze starch in the extract into sugar, heating to 77 ℃ to destroy the activity of the enzyme when the enzyme action is finished, adding 0.3-0.5% of active carbon, stirring at 55-60 ℃ for 20-30 minutes to decolorize pectin, adding 1-1.5% of diatomite, stirring uniformly, and filtering the extract by a filter press;
and step four, feeding the filtered pectin liquid into a vacuum concentration pot, keeping the vacuum degree above 667 mm Hg and the boiling point at about 50 ℃, concentrating until the total solid reaches 7-9%, after the concentration is finished, heating the pectin liquid to 70 ℃, putting the pectin liquid into a glass bottle, sealing the glass bottle with a cover, placing the glass bottle in hot water at 70 ℃, heating and sterilizing the glass bottle for 30 minutes, cooling, sealing and storing the glass bottle.
Preferably, the bacteriostatic and antiviral mechanism of the citrus flavonoid is that the chemical structure of hesperidin belongs to phenolic derivatives, and phenolic compounds and derivatives thereof are generally weakly acidic with pH of 6, can solidify or denature proteins, and thus have bacteriostatic and antiviral effects.
Preferably, the oral administration of the limonin can effectively and dose-dependently improve bleomycin-induced pulmonary fibrosis injury and inflammatory symptoms of the pathogenesis process of the mouse pulmonary fibrosis injury, and the detection of collagen synthesis shows that the limonin can down regulate the generation of alpha-SMA and collagen in a dose-dependent manner, and the effect is based on the inhibition of TGF-beta signal channels in mouse fibrotic lung tissues by phellodendron lactone.
Preferably, the pectin belongs to one of water-soluble dietary fibers, has certain viscosity, can prolong the retention time of the limonin and the citrus flavonoid in the throat to give full play to the efficacy, can form a thin protective film when reaching the stomach, can effectively relieve the stimulation of alcohol to the stomach, and simultaneously absorbs a large amount of water in the intestinal tract to keep the excrement in a wet state.
Preferably, the water-soluble fiber can effectively activate beneficial bacteria in the intestinal tract, promote mass propagation of the beneficial bacteria and create healthy ecology of the intestinal tract.
The invention has the technical effects and advantages that:
the phellodendron lactone can be applied to chronic lung diseases mediated by various inflammations including pulmonary fibrosis, chronic pneumonia, silicosis, chronic bronchitis, chronic obstructive pulmonary disease and asthma, the novel coronavirus infects serious lung inflammation injury of patients, the limonin and citrus flavonoid compounds are applied to the functional beverage, the problem that the traditional antiviral drugs have large toxic and side effects or are easy to generate drug resistance can be solved, the treatment and the later recovery of the patients are greatly facilitated, the pectin has certain viscosity, the residence time of the limonin and the citrus flavonoid in the throat can be prolonged, the effect can be fully exerted, a thin protective film can be formed when the pectin reaches the stomach, the stimulation of alcohol to the stomach can be effectively relieved, meanwhile, a large amount of water is absorbed in the intestinal tract, the feces can be kept in a wet state, and the actual effects of the limonin and the citrus flavonoid are increased, the bitter beverage has stronger efficacy of relieving the pulmonary fibrosis.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The invention provides a preparation method of a bitter beverage for relieving pulmonary fibrosis, which comprises the following steps:
step one, taking fresh lemons, cleaning, drying, peeling, removing seeds, juicing, filtering by using 150-mesh filter cloth, removing residues, and collecting lemon juice;
adding the citrus flavone, the limonin and the pectin into the lemon juice, adding water and honey for blending, and homogenizing the blended beverage;
and step three, filling the homogenized pulp into a sterilized glass bottle, sealing the glass bottle, sterilizing the glass bottle for 15-20 min at 85-86 ℃, and finally cooling the glass bottle to room temperature to obtain the bitter beverage, wherein the bitter beverage is rich in water-soluble fibers.
The purification method of the citrus flavonoid comprises the following steps:
step one, cleaning and crushing citrus peel, putting the crushed citrus peel and 50-95 v/v% ethanol water solution in an extractor according to the weight ratio of 1: 1-5, extracting for 0.5-1 hour under the reflux state, filtering, and repeating the step for 3 times;
step two, combining the filtered filtrates, concentrating to obtain a citrus peel extract, suspending the obtained citrus peel extract in water, and performing centrifugal filtration to obtain a clear filtrate;
step three, flowing the clear filtrate through an adsorption column filled with pretreated polystyrene type adsorption resin with the granularity of 0.3-1.25 mm at the flow rate of 1.5-8 BV/h at the temperature of 20-30 ℃, wherein the diameter of the adsorption column is as follows: the height ratio is 1: 3-30;
step four, water flows through the adsorption column at the flow rate of 5-10 BV/h; and finally, flowing methanol through the adsorption column at the flow rate of 2-10 BV/h, collecting the obtained liquid, and concentrating to obtain the citrus flavonoid.
The purification method of the limonin comprises the following steps:
step one, drying and crushing sweet orange seeds, thoroughly degreasing the sweet orange seeds for 24 hours by using petroleum ether (60-90 ℃) in a Soxhlet extractor, extracting the sweet orange seeds for 6 hours by using acetone, concentrating an acetone extracting solution under reduced pressure to dryness, dissolving the acetone extracting solution by using dichloromethane and filtering;
adding isopropanol with 2 times of volume into a dichloromethane solution, uniformly mixing, placing in a refrigerator at 4 ℃, and precipitating a flaky crystal;
step three, recrystallizing the obtained crystal I for 3 times according to the solvent system for determination, evaporating the crystallized mother liquor to dryness, and performing silica gel column chromatography to 100-200 meshes, wherein the eluent is ethyl acetate: methanol 95: 5, detecting with silica gel G thin layer chromatography plate, spraying Ehrlich reagent, mixing the components with the same red spot shift value, and limonin crystal.
The pectin purifying method comprises the following steps:
step one, soaking lemon peel and squeezed pomace in clear water for half an hour, heating to 90 ℃ for 5 minutes, pressing to remove juice, and rinsing with clear water for several times, so that most of glucoside, pigment and other impurities can be removed, and most of bitter taste is removed;
step two, pouring the ground raw materials into an extraction pot, adding 4 times of water, adding sulfurous acid to adjust the pH value to 1.8-2.7, introducing steam, heating to 95 ℃ while stirring, and keeping for 45-60 minutes to extract most of pectin;
filtering the sleeve extraction material through a filter press, separating impurities by using a 7000 r/min high-speed centrifuge, and then rapidly cooling to about 50 ℃; adding 1-2% amylase to hydrolyze starch in the extract into sugar, heating to 77 ℃ to destroy the activity of the enzyme when the enzyme action is finished, adding 0.3-0.5% of active carbon, stirring at 55-60 ℃ for 20-30 minutes to decolorize pectin, adding 1-1.5% of diatomite, stirring uniformly, and filtering the extract by a filter press;
and step four, feeding the filtered pectin liquid into a vacuum concentration pot, keeping the vacuum degree above 667 mm Hg and the boiling point at about 50 ℃, concentrating until the total solid reaches 7-9%, after the concentration is finished, heating the pectin liquid to 70 ℃, putting the pectin liquid into a glass bottle, sealing the glass bottle with a cover, placing the glass bottle in hot water at 70 ℃, heating and sterilizing the glass bottle for 30 minutes, cooling, sealing and storing the glass bottle.
The antibacterial and antiviral mechanism of the citrus flavonoid is that the chemical structure of hesperidin belongs to a phenolic derivative, and the phenolic compound and the derivatives thereof are generally weakly acidic pH (6) and can solidify or denature protein, so that the hesperidin has antibacterial and antiviral effects.
The oral administration of the limonin can effectively improve bleomycin-induced pulmonary fibrosis injury of mice and inflammatory symptoms of the onset process of the pulmonary fibrosis injury of the mice in a dose-dependent manner, and detection of collagen synthesis shows that the limonin can down-regulate the generation of alpha-SMA and collagen in a dose-dependent manner, and the effect is based on the inhibition of a TGF-beta signal channel in mouse fibrosis lung tissues by phellodendron lactone.
Pectin belongs to one of water-soluble dietary fibers, has certain viscosity, can prolong the retention time of limonin and citrus flavonoid in the throat to give full play to the efficacy, can form a thin protective film when reaching the stomach, can effectively relieve the stimulation of alcohol to the stomach, and simultaneously absorbs a large amount of water in the intestinal tract to keep the feces in a wet state.
The water-soluble fiber can effectively activate beneficial bacteria in the intestinal tract, promote mass propagation of the beneficial bacteria and create healthy ecology of the intestinal tract.
The working principle of the invention is as follows: cleaning fresh fructus Citri Limoniae, drying, peeling, removing seeds, squeezing, filtering with 150 mesh filter cloth, removing residue, and collecting lemon juice; adding citrus flavone, limonin and pectin into lemon juice, adding water and honey, blending, and homogenizing the blended beverage; filling the homogenized pulp into a sterilized glass bottle, sealing the glass bottle, sterilizing the glass bottle for 15 to 20min at the temperature of between 85 and 86 ℃, and finally cooling the glass bottle to room temperature to obtain bitter beverage, wherein the bitter beverage is rich in water-soluble fibers; the phellodendron lactone can be applied to chronic lung diseases mediated by various inflammations including pulmonary fibrosis, chronic pneumonia, silicosis, chronic bronchitis, chronic obstructive pulmonary disease and asthma, the novel coronavirus infects serious lung inflammation injury of patients, the limonin and citrus flavonoid compounds are applied to the functional beverage, the problem that the traditional antiviral drugs have large toxic and side effects or are easy to generate drug resistance can be solved, the treatment and the later recovery of the patients are greatly facilitated, the pectin has certain viscosity, the residence time of the limonin and the citrus flavonoid in the throat can be prolonged, the effect can be fully exerted, a thin protective film can be formed when the pectin reaches the stomach, the stimulation of alcohol to the stomach can be effectively relieved, meanwhile, a large amount of water is absorbed in the intestinal tract, the feces can be kept in a wet state, and the actual effects of the limonin and the citrus flavonoid are increased, the bitter beverage has stronger efficacy of relieving the pulmonary fibrosis.
In the description of the present invention, unless otherwise expressly specified or limited, the terms "disposed," "mounted," "connected," and "secured" are to be construed broadly, e.g., as meaning fixedly connected, detachably connected, or integral to; can be mechanically or electrically connected; either directly or indirectly through intervening media, either internally or in any other relationship. The specific meanings of the above terms in the present invention can be understood in specific cases to those skilled in the art.
The standard parts used by the invention can be purchased from the market, and the special-shaped parts can be customized according to the description of the specification.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (8)
1. A method of preparing a bitter beverage for relieving pulmonary fibrosis, comprising the steps of:
step one, taking fresh lemons, cleaning, drying, peeling, removing seeds, juicing, filtering by using 150-mesh filter cloth, removing residues, and collecting lemon juice;
adding the citrus flavone, the limonin and the pectin into the lemon juice, adding water and honey for blending, and homogenizing the blended beverage;
and step three, filling the homogenized pulp into a sterilized glass bottle, sealing the glass bottle, sterilizing the glass bottle for 15-20 min at 85-86 ℃, and finally cooling the glass bottle to room temperature to obtain the bitter beverage, wherein the bitter beverage is rich in water-soluble fibers.
2. The method of preparing a bitter beverage for relieving pulmonary fibrosis as recited in claim 1 wherein the purifying process of citrus flavonoid comprises the steps of:
step one, cleaning and crushing citrus peel, putting the crushed citrus peel and 50-95 v/v% ethanol water solution in an extractor according to the weight ratio of 1: 1-5, extracting for 0.5-1 hour under the reflux state, filtering, and repeating the step for 3 times;
step two, combining the filtered filtrates, concentrating to obtain a citrus peel extract, suspending the obtained citrus peel extract in water, and performing centrifugal filtration to obtain a clear filtrate;
step three, flowing the clear filtrate through an adsorption column filled with pretreated polystyrene type adsorption resin with the granularity of 0.3-1.25 mm at the flow rate of 1.5-8 BV/h at the temperature of 20-30 ℃, wherein the diameter of the adsorption column is as follows: the height ratio is 1: 3-30;
step four, water flows through the adsorption column at the flow rate of 5-10 BV/h; and finally, flowing methanol through the adsorption column at the flow rate of 2-10 BV/h, collecting the obtained liquid, and concentrating to obtain the citrus flavonoid.
3. The method of claim 1, wherein the purification of limonin comprises the steps of:
step one, drying and crushing sweet orange seeds, thoroughly degreasing the sweet orange seeds for 24 hours by using petroleum ether (60-90 ℃) in a Soxhlet extractor, extracting the sweet orange seeds for 6 hours by using acetone, concentrating an acetone extracting solution under reduced pressure to dryness, dissolving the acetone extracting solution by using dichloromethane and filtering;
adding isopropanol with 2 times of volume into a dichloromethane solution, uniformly mixing, placing in a refrigerator at 4 ℃, and precipitating a flaky crystal;
step three, recrystallizing the obtained crystal I for 3 times according to the solvent system for determination, evaporating the crystallized mother liquor to dryness, and performing silica gel column chromatography to 100-200 meshes, wherein the eluent is ethyl acetate: methanol 95: 5, detecting with silica gel G thin layer chromatography plate, spraying Ehrlich reagent, mixing the components with the same red spot shift value, and limonin crystal.
4. The method of claim 1, wherein the pectin purification process comprises the steps of:
step one, soaking lemon peel and squeezed pomace in clear water for half an hour, heating to 90 ℃ for 5 minutes, pressing to remove juice, and rinsing with clear water for several times, so that most of glucoside, pigment and other impurities can be removed, and most of bitter taste is removed;
step two, pouring the ground raw materials into an extraction pot, adding 4 times of water, adding sulfurous acid to adjust the pH value to 1.8-2.7, introducing steam, heating to 95 ℃ while stirring, and keeping for 45-60 minutes to extract most of pectin;
filtering the sleeve extraction material through a filter press, separating impurities by using a 7000 r/min high-speed centrifuge, and then rapidly cooling to about 50 ℃; adding 1-2% amylase to hydrolyze starch in the extract into sugar, heating to 77 ℃ to destroy the activity of the enzyme when the enzyme action is finished, adding 0.3-0.5% of active carbon, stirring at 55-60 ℃ for 20-30 minutes to decolorize pectin, adding 1-1.5% of diatomite, stirring uniformly, and filtering the extract by a filter press;
and step four, feeding the filtered pectin liquid into a vacuum concentration pot, keeping the vacuum degree above 667 mm Hg and the boiling point at about 50 ℃, concentrating until the total solid reaches 7-9%, after the concentration is finished, heating the pectin liquid to 70 ℃, putting the pectin liquid into a glass bottle, sealing the glass bottle with a cover, placing the glass bottle in hot water at 70 ℃, heating and sterilizing the glass bottle for 30 minutes, cooling, sealing and storing the glass bottle.
5. The method of claim 1, wherein the anti-bacterial and antiviral mechanism of citrus flavonoid is that hesperidin has a chemical structure of phenolic derivatives, phenolic compounds and derivatives thereof, generally having a weak acidic PH of 6, and is capable of coagulating or denaturing proteins, thereby having anti-bacterial and antiviral effects.
6. The method of claim 1, wherein the oral administration of limonin is effective to dose-dependently ameliorate the inflammatory symptoms of bleomycin-induced pulmonary fibrosis injury and its pathogenesis in mice, and the detection of collagen synthesis indicates that limonin can dose-dependently down-regulate the production of α -SMA and collagen, based on the inhibition of TGF- β signaling pathway in fibrotic lung tissue in mice by phellodendron lactone.
7. The method of claim 1, wherein the pectin is one of water-soluble dietary fibers, has viscosity, and is effective in prolonging the residence time of limonin and citrus flavonoid in the throat to form a thin protective film on the stomach, thereby effectively relieving the irritation of alcohol to the stomach, and absorbing a large amount of water in the intestinal tract to keep the feces in a wet state.
8. The method of claim 1, wherein the water-soluble fiber is effective to activate beneficial bacteria in the intestinal tract, promote mass propagation of beneficial bacteria, and create a healthy gut ecology.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111439198.XA CN114097965A (en) | 2021-11-30 | 2021-11-30 | Preparation method of bitter beverage for relieving pulmonary fibrosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111439198.XA CN114097965A (en) | 2021-11-30 | 2021-11-30 | Preparation method of bitter beverage for relieving pulmonary fibrosis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114097965A true CN114097965A (en) | 2022-03-01 |
Family
ID=80368119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111439198.XA Pending CN114097965A (en) | 2021-11-30 | 2021-11-30 | Preparation method of bitter beverage for relieving pulmonary fibrosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114097965A (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1810819A (en) * | 2006-03-03 | 2006-08-02 | 华东理工大学 | Process of preparing tangeritin from orange peel |
CN105924542A (en) * | 2016-06-22 | 2016-09-07 | 平凉市佳禾农产品加工有限责任公司 | Method for extracting pectin from glutinous corn |
CN109511839A (en) * | 2018-11-15 | 2019-03-26 | 天门市怡田饮品科技有限公司 | A kind of honey kumquat lemon beverage |
CN110423287A (en) * | 2019-07-15 | 2019-11-08 | 海南热带海洋学院 | Jackfruit skin pectin extraction method |
CN111919983A (en) * | 2020-07-20 | 2020-11-13 | 莱檬(清远市)生物科技有限公司 | Bitter health-care beverage and preparation method thereof |
CN112544834A (en) * | 2020-12-02 | 2021-03-26 | 华南师范大学 | Preparation method of bitter beverage for preventing and treating chronic pharyngitis |
CN113501892A (en) * | 2021-07-23 | 2021-10-15 | 江西莱檬生物科技有限责任公司 | Combined extraction method for different functional components in citrus fruit peel residues |
-
2021
- 2021-11-30 CN CN202111439198.XA patent/CN114097965A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1810819A (en) * | 2006-03-03 | 2006-08-02 | 华东理工大学 | Process of preparing tangeritin from orange peel |
CN105924542A (en) * | 2016-06-22 | 2016-09-07 | 平凉市佳禾农产品加工有限责任公司 | Method for extracting pectin from glutinous corn |
CN109511839A (en) * | 2018-11-15 | 2019-03-26 | 天门市怡田饮品科技有限公司 | A kind of honey kumquat lemon beverage |
CN110423287A (en) * | 2019-07-15 | 2019-11-08 | 海南热带海洋学院 | Jackfruit skin pectin extraction method |
CN111919983A (en) * | 2020-07-20 | 2020-11-13 | 莱檬(清远市)生物科技有限公司 | Bitter health-care beverage and preparation method thereof |
CN112544834A (en) * | 2020-12-02 | 2021-03-26 | 华南师范大学 | Preparation method of bitter beverage for preventing and treating chronic pharyngitis |
CN113501892A (en) * | 2021-07-23 | 2021-10-15 | 江西莱檬生物科技有限责任公司 | Combined extraction method for different functional components in citrus fruit peel residues |
Non-Patent Citations (3)
Title |
---|
作者不详: "冠清柠柠檬苦饮主要有什么作用", pages 1 - 2, Retrieved from the Internet <URL:https://tieba.baidu.com/p/6607175060> * |
作者不详: "冠清柠柠檬苦饮的主要成分是什么?", pages 1, Retrieved from the Internet <URL:https://zhidao.baidu.com/question/1708681072695715420.html> * |
田庆国 等: "甜橙种子中柠檬苦素类化合物的提取", 林产化学与工业, vol. 19, no. 3, pages 2 - 6 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2020048049A1 (en) | Method for preparing luo han guo sweetener composition from siraitia grosvenorii and use thereof | |
CN105767396A (en) | Lipid-lowering ginkgo seed tea | |
CN101386636B (en) | Mogroside extraction method from grosvenor momordica | |
CN105767397A (en) | Spleen-invigorating and stomach-harmonizing gingko tea | |
CN101327244A (en) | Decolored and debitterized Momordica grosvenori extract and preparation method thereof | |
CN103735633B (en) | A kind of preparation method of instant gardenia powder | |
CN108752231A (en) | The method extracted theanine from Sweet tea and extract Rubusoside and tea polyphenols simultaneously | |
CN110105458A (en) | The method that polysaccharide and PEARLITOL 25C are extracted in waste liquid is extracted from mogroside | |
CN105961983A (en) | Solid beverage and preparation method thereof | |
CN100575357C (en) | A kind of method of from glutinous rehmannia, extracting rehmannia root oligose and Dihuang polysaccharide simultaneously | |
CN106509323A (en) | Sweets capable of clearing heat from throat and improving condition of throat and preparation method of sweets | |
CN102178004B (en) | Health-care Puer tea drink | |
CN102114182B (en) | Compound preparation for resisting heat stress and heat fatigue | |
CN103999986B (en) | A kind of cold tea condensed juice and preparation method thereof | |
CN108686113A (en) | A kind of composition and preparation method thereof for alleviating three high diseases shape | |
CN114097965A (en) | Preparation method of bitter beverage for relieving pulmonary fibrosis | |
CN106943464A (en) | A kind of biological nutrition compound composition of adjusting hypertension | |
CN105876017A (en) | Ginkgo health tea | |
CN102690359B (en) | A kind of method extracting starch and cucurbitacin from Fructus Momordicae tuber | |
CN108740227A (en) | A kind of fruit tea and preparation method thereof | |
KR20190101063A (en) | Composition containing natural material extract for preventing and improving respiratory organ disease | |
CN108497246A (en) | A kind of plant weight losing function beverage and preparation method thereof | |
KR102282839B1 (en) | Composition for relieving or improving hangover | |
CN112970923A (en) | Plant extract for flavoring syrup | |
CN102430006B (en) | Method for extracting purified polyphenol from young fruits of lycium chinense |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 511500 No. 01, floor 3, building l08, Tianan Zhigu science and Technology Industrial Park, No. 18, Chuangxing Avenue, Qingyuan high tech Industrial Development Zone, Qingyuan City, Guangdong Province Applicant after: Guangdong Guanqingling Biotechnology Co.,Ltd. Address before: No.1, C01, headquarters building, Tianan Zhigu science and Technology Industrial Park, 18 Chuangxing Avenue, Qingyuan high tech Zone, Qingyuan City, Guangdong Province, 511500 Applicant before: Limeng (Qingyuan) Biotechnology Co.,Ltd. |
|
CB02 | Change of applicant information |